We are live on
!
Find out more
PC
Polar Capital Portfolio holdings
AUM
$13.5B
1-Year Est. Return
55.9%
This Fund
S&P 500
This Quarter
Est. Return
+10.97%
1 Year Est. Return
+55.9%
3 Year Est. Return
+127.44%
5 Year Est. Return
+269.08%
10 Year Est. Return
–
AUM
$11.8B
AUM Growth
+$11.7B
(+70,685%)
Cap. Flow
+$973M
Cap. Flow
% of AUM
8.28%
Top 10 Holdings %
Top 10 Hldgs %
24.41%
Holding
296
New
40
Increased
100
Reduced
97
Closed
30
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$166M |
| 2 |
Amgen
AMGN
|
+$123M |
| 3 |
Autodesk
ADSK
|
+$114M |
| 4 |
UnitedHealth
UNH
|
+$103M |
| 5 |
Merck
MRK
|
+$102M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$78.6M |
| 2 |
Advanced Micro Devices
AMD
|
+$74.2M |
| 3 |
Thermo Fisher Scientific
TMO
|
+$65.6M |
| 4 |
Union Pacific
UNP
|
+$36.4M |
| 5 |
Illumina
ILMN
|
+$26.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.57% |
| 2 | Financials | 22.21% |
| 3 | Healthcare | 21.91% |
| 4 | Communication Services | 9.53% |
| 5 | Industrials | 7.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Pegasystems
PEGA
$4.7B
| $36.8M | 0.31% |
1,175,260
-209,324
| -15% | -$6.33M |
|
|
KL
102
DELISTED
Kirkland Lake Gold Ltd Ordinary
KL
| $36.2M | 0.31% |
1,656,912
-1,014,295
| -38% | -$20.7M |
|
|
PFPT
103
DELISTED
Proofpoint, Inc.
PFPT
| $36.2M | 0.31% |
340,242
+85,949
| +34% | +$10M |
|
104
Monolithic Power Systems
MPWR
$65.8B
| $35.9M | 0.31% |
285,778
+68,438
| +31% | +$9.54M |
|
|
AXON
105
Axon Enterprise
AXON
$42.4B
| $35.3M | 0.3% |
516,206
-64,670
| -11% | -$4.36M |
|
106
LivaNova
LIVN
$4.43B
| $34.5M | 0.29% |
278,256
+44,856
| +19% | +$5.29M |
|
|
STML
107
DELISTED
Stemline Therapeutics, Inc.
STML
| $34.1M | 0.29% |
2,054,050
+141,445
| +7% | +$2.27M |
|
108
Dropbox
DBX
$7.13B
| $34.1M | 0.29% |
1,270,774
+313,238
| +33% | +$9.05M |
|
|
RHT
109
DELISTED
Red Hat Inc
RHT
| $34M | 0.29% |
249,451
-125,542
| -33% | -$18M |
|
110
Texas Instruments
TXN
$255B
| $33.9M | 0.29% |
315,498
+83,278
| +36% | +$9.26M |
|
|
TWOU
111
DELISTED
2U Inc
TWOU
| $33.2M | 0.28% |
14,732
+2,253
| +18% | +$5.57M |
|
|
MDSO
112
DELISTED
Medidata Solutions, Inc.
MDSO
| $32.8M | 0.28% |
447,085
-83,086
| -16% | -$6.65M |
|
113
Neurocrine Biosciences
NBIX
$17.7B
| $32.6M | 0.28% |
+265,303
| New | +$30.1M |
|
114
8x8 Inc
EGHT
$262M
| $32.4M | 0.28% |
1,526,081
-24,420
| -2% | -$532K |
|
115
Incyte
INCY
$23.7B
| $31.9M | 0.27% |
462,342
-162,658
| -26% | -$11.2M |
|
|
DCPH
116
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $31.2M | 0.27% |
805,004
+210,453
| +35% | +$7.78M |
|
117
HubSpot
HUBS
$11.4B
| $30.8M | 0.26% |
204,235
-41,553
| -17% | -$5.71M |
|
118
ICU Medical
ICUI
$4.04B
| $30.6M | 0.26% |
108,312
-2,203
| -2% | -$645K |
|
119
The Mosaic Company
MOS
$7.1B
| $30M | 0.26% |
+923,529
| New | +$27.8M |
|
120
Everest Group
EG
$15.4B
| $29.7M | 0.25% |
130,000
+32,500
| +33% | +$7.27M |
|
121
Taylor Morrison
TMHC
| $29.6M | 0.25% |
1,642,062
+48,450
| +3% | +$963K |
|
122
Amphenol
APH
$184B
| $28.8M | 0.25% |
+1,225,552
| New | +$28.5M |
|
|
MDC
123
DELISTED
M.D.C. Holdings, Inc.
MDC
| $28M | 0.24% |
1,105,755
+29,228
| +3% | +$783K |
|
124
Affiliated Managers Group
AMG
$9.61B
| $27.9M | 0.24% |
204,092
+5,438
| +3% | +$803K |
|
|
LHCG
125
DELISTED
LHC Group LLC
LHCG
| $27.8M | 0.24% |
270,158
+28,158
| +12% | +$2.63M |
|
Similar funds
ECM
FAAS
WAM
FS
NIMC
TI
VIM
PS
Polar Capital's Q3 2018 Portfolio in Review
As of Q3 2018, Polar Capital held 296 positions worth $11.8B, up 70,685% from $16.6M the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Polar Capital deployed $973M of net new capital in Q3 2018, opening 40 new positions and adding to 100 existing holdings. Its largest new stake was Johnson & Johnson: 1,250,000 shares worth $173M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $78.6M trimmed.
- Polar Capital's largest Q3 2018 buy was Johnson & Johnson: 1,250,000 shares worth $173M.
- Polar Capital added most to UnitedHealth in Q3 2018, an estimated $103M increase.
- Polar Capital's biggest Q3 2018 reduction was Meta Platforms (Facebook), cutting an estimated $78.6M.
- Polar Capital fully exited Amdocs in Q3 2018, selling an estimated $46.6K.
- Polar Capital's ten largest holdings make up 24% of its $11.8B portfolio in Q3 2018.
- Polar Capital opened 40 new positions and closed 30 in Q3 2018.
- Polar Capital's portfolio value rose 70,685% quarter-over-quarter to $11.8B.
Based on Polar Capital's 13F filing for Q3 2018, filed 14 Nov 2018.